Predicting cholecystocholedochal fistulas in patients with Mirizzi syndrome undergoing endoscopic retrograde cholangiopancreatography

doi:10.3748/wjg.v26.i40.6241

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7474)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

347

WORD

149

HTML

3580

Figures (1-3)

558

Tables (1-3)

277

Sum=4911

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

812

Download

1751

Sum=2563

Oct 28, 2020 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 28, 2020; 26(40): 6241-6249
Published online Oct 28, 2020. doi: 10.3748/wjg.v26.i40.6241

Table 2 Comparison of endoscopic retrograde cholangiopancreatography findings in patients with Mirizzi syndrome with or without cholecystocholedochal fistula formation, n (%)

	MS with fistula formation, n = 21	MS without fistula formation, n = 96	P value
Original findings
Cystic duct opacification	10 (47.61)	46 (47.92)	0.81
GB opacification	16 (76.19)	26 (23.96)	< 0.001
Additional findings
Stricture length > 2 cm	2 (9.52)	41 (42.71)	0.005
CBD stones retrieved	2 (9.52)	28 (29.17)	0.09
Pus in the CBD	10 (47.62)	15 (15.63)	0.003
Duodenal ulcer	6 (28.57)	19 (19.79)	0.39

CBD: Common bile duct; ERCP: Endoscopic retrograde cholangiopancreatography; GB: Gall bladder; MS: Mirizzi syndrome.

Citation: Wu CH, Liu NJ, Yeh CN, Wang SY, Jan YY. Predicting cholecystocholedochal fistulas in patients with Mirizzi syndrome undergoing endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2020; 26(40): 6241-6249
URL: https://www.wjgnet.com/1007-9327/full/v26/i40/6241.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i40.6241